
Ceftasis S 1000mg/500mg Injection
Marketer
Biogensis Biotechnic
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Ceftasis S 1000mg/500mg Injection
Combiflox, a dual-action injectable medication (1000mg/500mg), combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be under a physician's direct oversight; adherence to the prescribed schedule is crucial for efficacy. Complete the full treatment course, even with symptom improvement, to prevent recurrence. Premature cessation may compromise its effectiveness. Minor side effects like nausea, vomiting, diarrhea, and dyspepsia may occur. Severe reactions necessitate immediate medical consultation. Allergic responses (e.g., skin rash, itching, edema, respiratory distress) require emergency care. Disclose all current medications to your doctor before use, including those for pre-existing conditions. Pregnant or lactating individuals should consult their physician prior to treatment. Alcohol consumption is contraindicated due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing drowsiness or dizziness. Rest, a nutritious diet, and hydration are vital for optimal recovery. Your physician may order blood tests and other assessments to monitor treatment response.
Primary Ingredients of Ceftasis S 1000mg/500mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Ceftasis S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Ceftasis S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ceftasis S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ceftasis S 1000mg/500mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Ceftasis S 1000mg/500mg Injection works:
Ceftasis S Injection (1000mg/500mg) unites Ceftriaxone, a broad-spectrum antibiotic, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their growth and survival. Sulbactam counters bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Ceftasis S 1000mg/500mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Ceftasis S 1000mg/500mg Injection is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Ceftasis S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ceftasis S 1000mg/500mg Injection may induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Ceftasis S 1000mg/500mg Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCAUTION
Individuals with severe hepatic impairment should use Ceftasis S 1000mg/500mg Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alteration of Ceftasis S 1000mg/500mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Ceftasis S 1000mg/500mg Injection :
Omit a Ceftasis S 1000mg/500mg Injection dose? Seek your physician's advice.
Facts to Know About Ceftasis S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
